Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sacramento, CA
NPI
1811382559
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4860 Y St Ste B0100
Sacramento, CA, 95817
Phone (916) 734-2737
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
2,385 services
Medicare patients, 2024
440
Average age 73
Drug cost, 2024
$1.3M
1,835 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Polly F Teng was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 331 times for 266 patients. In total Polly F Teng billed 2,385 services in 26 codes, and Medicare paid $92K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 331 | 266 | $13.27 | $4,393 |
| 99215 Office E&M - Established | Facility | 297 | 210 | $106.49 | $32K |
| 99214 Office E&M - Established | Facility | 250 | 202 | $72.06 | $18K |
| 99205 Office E&M - New | Facility | 61 | 61 | $132.03 | $8,054 |
| 95251 Test - Miscellaneous | Facility | 60 | 26 | $27.21 | $1,633 |
| 99232 Hospital E&M - Subsequent | Facility | 41 | 18 | $63.29 | $2,595 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 35 | 22 | $13.43 | $470 |
| 99204 Office E&M - New | Facility | 26 | 26 | $101.06 | $2,628 |
| 99223 Hospital E&M - Initial | Facility | 20 | 19 | $139.20 | $2,784 |
| 99215 Office E&M - Established | Office | 17 | 13 | $151.17 | $2,570 |
| 99205 Office E&M - New | Office | 11 | 11 | $183.44 | $2,018 |
By year: 2022 $73K for 973 services; 2023 $47K for 479 services; 2024 $92K for 2,385 services.
Medicare prescription drug claims, 2024
In 2024, the drug Polly F Teng prescribed most often to Medicare patients was Levothyroxine Sodium, with 321 prescriptions and refills. In total Polly F Teng wrote 1,835 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 321 | 812 | 81 | $7,433 |
| Alendronate Sodium Generic | 198 | 555 | 66 | $2,920 |
| Forteo Teriparatide | 145 | 152 | 23 | $536K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 93 | 237 | 37 | $6,423 |
| Ozempic Semaglutide | 82 | 125 | 16 | $112K |
| Trulicity Dulaglutide | 69 | 111 | 13 | $103K |
| Teriparatide Generic | 59 | 62 | 11 | $142K |
| Tymlos Abaloparatide | 58 | 60 | Under 11 | $152K |
| Synthroid Levothyroxine Sodium | 55 | 146 | 11 | $4,196 |
| Metformin Hcl Er Metformin Hcl | 46 | 124 | 18 | $936 |
| Single Use Swab Alcohol Antiseptic Pads | 36 | 111 | 16 | $73.7 |
| Jardiance Empagliflozin | 35 | 87 | 12 | $47K |
| Hydrocortisone Generic | 34 | 89 | Under 11 | $2,204 |
| Mounjaro Tirzepatide | 33 | 35 | Under 11 | $36K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 33 | 98 | 13 | $4,811 |
Brand drugs: 880 claims; generic drugs: 754 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Polly F Teng were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.